Results 1 to 10 of about 22,657 (185)

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set : translation and cross-cultural adaptation into 15 languages [PDF]

, 2016
Introduction: The Assessments of SpondyloArthritis international society Health Index (ASAS HI) measures functioning and health in patients with spondyloarthritis (SpA) across 17 aspects of health and 9 environmental factors (EF).
Bautista-Molano, W, Boonen, A, Braun, J, Burgos-Vargas, R, Chiowchanwisawakit, P, Duruoz, T, El-Zorkany, B, Essers, I, Gaydukova, I, Gossec, L, Grazio, S, Gu, J, Géher, P, Khan, MA, Kiltz, U, Kim, TJ, Maksymowych, WP, Marzo-Ortega, H, Navarro-Compán, V, Olivieri, I, Patrikos, D, Pimentel-Santos, FM, Schirmer, M, Van den Bosch, Filip, van der Heijde, D, Weber, U, Zochling, J   +26 more
core   +22 more sources

Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review

BMC Musculoskeletal Disorders, 2022
Background Optimal treatment of nonradiographic axial spondyloarthritis depends on accurate and timely diagnosis of the underlying disease; however, patients present with common symptoms that, in the absence of radiographic changes, may confound ...
Philip Mease, Atul Deodhar
doaj   +1 more source

MRI Workshop for Axial Spondyloarthritis 2023 Interpretation of MRI SI Joint

Journal of Clinical Rheumatology and Immunology, 2023
MRI sacroiliac joint is a sensitive imaging modality for evaluation of inflammation and the accompanying structural changes. Assessment of SpondyloArthritis international Society (ASAS) classification criteria incorporates active inflammation of the ...
Victor LEE
doaj   +1 more source

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). [PDF]

, 2020
OBJECTIVES: To investigate the efficacy and safety of ixekizumab for up to 52 weeks in two phase 3 studies of patients with active radiographic axial spondyloarthritis (r-axSpA) who were biological disease-modifying antirheumatic drug (bDMARD)-naive ...
Baraliakos, X., Bertram, C.C., Bosch, F. van den, Carlier, H., COAST-V Study Grp, COAST-W Study Grp, Deodhar, A., Dougados, M., Ermann, J., Gallo, G., Gensler, L.S., Heijde, D. van der, Landewe, R., Li, X.Q., Maksymowych, W.P., Sieper, J., Tomita, T., Walsh, J.A., Wei, J.C.C., Zhao, F.Y.   +19 more
core   +3 more sources

Emerging imaging techniques in spondyloarthritis dual-energy computed tomography and new MRI sequences [PDF]

, 2020
Imaging of the sacroiliac joint plays a critical role in the classification of patients with axial spondyloarthritis. New imaging techniques are emerging, changing the way clinicians look at the sacroiliac joint.
Bird, Paul, Chen, Min, Jans, Lennart
core   +1 more source

Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis.

PLoS ONE, 2020
Spondyloarthritis Research Consortium Canada (SPARCC) score is an effective magnetic resonance imaging (MRI) evaluation method for inflammation in axial spondyloarthritis.
Yupeng Huang, Yuehong Chen, Tao Liu, Sang Lin, Geng Yin, Qibing Xie   +5 more
doaj   +1 more source

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?

Frontiers in Immunology, 2021
Axial spondyloarthritis is a prevalent form of chronic arthritis which is related to psoriatic arthritis and skin psoriasis. TNF and IL-17A as well as IL-17F are key cytokines contributing to the pathobiology of this disease, as evidence by the ...
Dominique Baeten, Dominique Baeten, Iannis E. Adamopoulos   +2 more
doaj   +1 more source

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis : 48-week results from the EMBARK study [PDF]

, 2015
Objective: To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA).
Bonin, Randi, Braun, Jürgen, Bukowski, Jack F, Citera, Gustavo, Dougados, Maxime, Jones, Heather, Kotak, Sameer, Logeart, Isabelle, Maksymowych, Walter P, Marshall, Lisa, Pedersen, Ron, Sieper, Joachim, Van den Bosch, Filip, van der Heijde, Désirée, Vlahos, Bonnie, Wajdula, Joseph   +15 more
core   +1 more source

Diagnostic value of MRI of the sacroiliac joints in juvenile spondyloarthritis [PDF]

, 2016
Early diagnosis of spondyloarthritis (SpA) is becoming more important as new medical treatment options have become available to treat inflammation and delay progression of the disease.
Baraliakos, Xenofon, Dehoorne, Jo, Herregods, Nele, Jans, Lennart, Jaremko, Jacob, Joos, Rik, Verstraete, Koenraad   +6 more
core   +1 more source

The perspective of people with axial spondyloarthritis regarding physiotherapy : room for the implementation of a more active approach [PDF]

, 2019
Objectives. Physiotherapy is recommended in the management of people with axial spondyloarthritis (axSpA), with new insights into its preferred content and dosage evolving.
Goekoop-Ruiterman, Yvonne P M, Meichtry, André, Niedermann Schneider, Karin, Osthoff, Anne-Kathrin Rausch, Peeters, Andreas J, van der Giesen, Florus, van Gaalen, Floris A, Vliet Vlieland, Theodora P M, Walker, Beatrice   +8 more
core   +1 more source